Recombinant Human IFITM2 Protein，His

IFITM2 (Interferon-Inducible Transmembrane Protein 2) is a member of the IFITM family, which plays a critical role in the innate immune response to viral infections. Discovered as an interferon-stimulated gene, IFITM2 is known for its ability to restrict the entry of various enveloped viruses, including influenza, HIV, and West Nile virus, into host cells. This restriction occurs at the level of viral membrane fusion, highlighting the protein’s function as a crucial barrier against viral propagation. Research into IFITM2 has expanded to explore its regulatory mechanisms, cellular localization, and potential therapeutic applications, particularly in enhancing antiviral strategies. Furthermore, the understanding of IFITM2's interactions with host cell factors and its role in immune signaling pathways may provide insights into the development of immune-based treatments. As viral pathogens evolve and develop resistance to traditional antiviral drugs, elucidating the mechanisms by which IFITM2 mediates its antiviral effects is of significant scientific interest, potentially paving the way for novel interventions in viral diseases. Therefore, recombinant IFITM2 protein has become a valuable tool for study, allowing researchers to investigate its structure-function relationships, assess its effectiveness in different viral contexts, and develop potential therapeutic applications to combat viral infections in an era of emerging and re-emerging viral threats.